Enrolling study
Postmenopausal Health Research Study
A women's health research study for postmenopausal adults, evaluating an investigational treatment and related symptom measures.
About this study
The study team reviews symptom diaries and performs standard assessments at each visit. Enrollment for this study is expected to open soon.
- Condition
- Postmenopausal Health
- Age range
- 45–70
- Estimated duration
- About 8 months
- Study visits
- 6
Eligibility snapshot
- Women 45–70 years of age
- Postmenopausal status per protocol definition
- Willing to complete a symptom diary
- Able to attend scheduled study visits
What to expect
- 1Screening visit with informed consent review
- 2Approximately 6 study visits
- 3Symptom diary completed at home
- 4Routine laboratory and safety monitoring
Compensation
Compensation for time and travel may be available.
Location & Principal Investigator
8500 Example Medical Plaza, Suite 210, Miami, FL 33176
Studies at this site are conducted by our Principal Investigators and research staff.
Frequently asked questions
Answers to questions we hear most often.
What does participation involve?
Participation involves scheduled study visits with assessments defined by the protocol. Everything that will be asked of you is described in the informed consent document before you decide.
How long is the study?
The estimated duration is listed above. Your coordinator will review the full visit schedule with you during the consent process.
Will I be compensated for time and travel?
Where compensation is offered, the amount and payment schedule are described in the informed consent document and reviewed with you before enrollment.
What are the eligibility requirements?
The listing above shows a high-level snapshot. Full criteria are defined in the protocol and confirmed by the study team at a screening visit.
Can I leave the study at any time?
Yes. Participation is voluntary and you may withdraw at any time. Your coordinator will discuss any recommended safety follow-up.
Is my information kept confidential?
Yes. Access is limited to delegated study staff, and information shared with the sponsor is coded wherever the protocol allows.
Think you may qualify?
Contact us to learn more. A short conversation is all it takes to find out whether a screening visit makes sense.
Contact us to pre-screenThis study is conducted under IRB oversight in accordance with Good Clinical Practice guidelines. Eligibility is confirmed by the study team; the information here is a summary and not a full protocol.